Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties

DOI record: { "DOI": "10.1016/j.ijpharm.2022.121719", "ISSN": [ "0378-5173" ], "URL": "http://dx.doi.org/10.1016/j.ijpharm.2022.121719", "alternative-id": [ "S0378517322002745" ], "article-number": "121719", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Journal of Pharmaceutics" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ijpharm.2022.121719" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 Elsevier B.V. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Zheng", "given": "Jinpeng", "sequence": "first" }, { "affiliation": [], "family": "Lu", "given": "Caihong", "sequence": "additional" }, { "affiliation": [], "family": "Ding", "given": "Yaning", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Jinbang", "sequence": "additional" }, { "affiliation": [], "family": "Tan", "given": "Fangyun", "sequence": "additional" }, { "affiliation": [], "family": "Liu", "given": "Jingzhou", "sequence": "additional" }, { "affiliation": [], "family": "Yang", "given": "Guobao", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Yuli", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Zhiping", "sequence": "additional" }, { "affiliation": [], "family": "Yang", "given": "Meiyan", "sequence": "additional" }, { "affiliation": [], "family": "Yang", "given": "Yang", "sequence": "additional" }, { "affiliation": [], "family": "Gong", "given": "Wei", "sequence": "additional" }, { "affiliation": [], "family": "Gao", "given": "Chunsheng", "sequence": "additional" } ], "container-title": [ "International Journal of Pharmaceutics" ], "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 4, 4 ] ], "date-time": "2022-04-04T15:30:17Z", "timestamp": 1649086217000 }, "deposited": { "date-parts": [ [ 2022, 4, 12 ] ], "date-time": "2022-04-12T02:03:23Z", "timestamp": 1649729003000 }, "funder": [ { "DOI": "10.13039/501100013076", "award": [ "2018ZX09711003-008-001" ], "doi-asserted-by": "publisher", "name": "National Major Science and Technology Projects of China" } ], "indexed": { "date-parts": [ [ 2022, 4, 12 ] ], "date-time": "2022-04-12T02:41:46Z", "timestamp": 1649731306658 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "0378-5173" } ], "issued": { "date-parts": [ [ 2022, 5 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 5, 1 ] ], "date-time": "2022-05-01T00:00:00Z", "timestamp": 1651363200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0378517322002745?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0378517322002745?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "121719", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 5 ] ] }, "published-print": { "date-parts": [ [ 2022, 5 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.addr.2010.10.008", "article-title": "PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect", "author": "Acharya", "doi-asserted-by": "crossref", "first-page": "170", "issue": "3", "journal-title": "Adv. Drug Deliv. Rev.", "key": "10.1016/j.ijpharm.2022.121719_b0005", "volume": "63", "year": "2011" }, { "DOI": "10.1016/j.ijid.2020.11.191", "article-title": "A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness", "author": "Ahmed", "doi-asserted-by": "crossref", "first-page": "214", "journal-title": "International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases", "key": "10.1016/j.ijpharm.2022.121719_b0010", "volume": "103", "year": "2021" }, { "DOI": "10.2147/DDDT.S99651", "article-title": "Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery", "author": "Ahmed", "doi-asserted-by": "crossref", "first-page": "483", "journal-title": "Drug Des Devel Ther", "key": "10.1016/j.ijpharm.2022.121719_b0015", "volume": "10", "year": "2016" }, { "DOI": "10.1021/nn404853z", "article-title": "Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells", "author": "Anselmo", "doi-asserted-by": "crossref", "first-page": "11129", "issue": "12", "journal-title": "ACS Nano", "key": "10.1016/j.ijpharm.2022.121719_b0020", "volume": "7", "year": "2013" }, { "DOI": "10.1016/j.jconrel.2014.03.050", "article-title": "Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles", "author": "Anselmo", "doi-asserted-by": "crossref", "first-page": "531", "journal-title": "J Control Release", "key": "10.1016/j.ijpharm.2022.121719_b0025", "volume": "190", "year": "2014" }, { "DOI": "10.1038/s41467-017-00600-w", "article-title": "Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics", "author": "Bertrand", "doi-asserted-by": "crossref", "first-page": "777", "journal-title": "Nat. Commun.", "key": "10.1016/j.ijpharm.2022.121719_b0030", "volume": "8", "year": "2017" }, { "DOI": "10.1146/annurev-bioeng-121219-024239", "article-title": "Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers", "author": "Brenner", "doi-asserted-by": "crossref", "first-page": "225", "issue": "1", "journal-title": "Annu Rev Biomed Eng", "key": "10.1016/j.ijpharm.2022.121719_b0035", "volume": "23", "year": "2021" }, { "DOI": "10.1038/s41467-018-05079-7", "article-title": "Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude", "author": "Brenner", "doi-asserted-by": "crossref", "first-page": "2684", "journal-title": "Nat. Commun.", "key": "10.1016/j.ijpharm.2022.121719_b0040", "volume": "9", "year": "2018" }, { "DOI": "10.1016/j.antiviral.2020.104787", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0045", "unstructured": "Caly, L., Druce, J.D., Catton, M.G., Jans, D.A., Wagstaff, K.M., 2020. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral research 178, 104787." }, { "DOI": "10.1021/nn901372t", "article-title": "Time evolution of the nanoparticle protein corona", "author": "Casals", "doi-asserted-by": "crossref", "first-page": "3623", "issue": "7", "journal-title": "ACS Nano", "key": "10.1016/j.ijpharm.2022.121719_b0050", "volume": "4", "year": "2010" }, { "DOI": "10.1016/j.jconrel.2004.08.005", "article-title": "Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes", "author": "Chambers", "doi-asserted-by": "crossref", "first-page": "111", "issue": "1", "journal-title": "J Control Release", "key": "10.1016/j.ijpharm.2022.121719_b0055", "volume": "100", "year": "2004" }, { "DOI": "10.1038/nature01326", "article-title": "The immunopathogenesis of sepsis", "author": "Cohen", "doi-asserted-by": "crossref", "first-page": "885", "issue": "6917", "journal-title": "Nature", "key": "10.1016/j.ijpharm.2022.121719_b0060", "volume": "420", "year": "2002" }, { "DOI": "10.1155/2016/8043983", "article-title": "Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin", "author": "Croci", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "International journal of biomaterials", "key": "10.1016/j.ijpharm.2022.121719_b0065", "volume": "2016", "year": "2016" }, { "DOI": "10.1016/j.jconrel.2021.12.018", "article-title": "RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery", "author": "Ding", "doi-asserted-by": "crossref", "first-page": "702", "journal-title": "J Control Release", "key": "10.1016/j.ijpharm.2022.121719_b0070", "volume": "341", "year": "2021" }, { "article-title": "microRNA-1246 mediates lipopolysaccharide-induced pulmonary endothelial cell apoptosis and acute lung injury by targeting angiotensin-converting enzyme 2", "author": "Fang", "first-page": "1287", "journal-title": "American journal of translational research", "key": "10.1016/j.ijpharm.2022.121719_b0075", "volume": "9", "year": "2017" }, { "DOI": "10.1016/j.jconrel.2020.10.009", "article-title": "Ivermectin: an award-winning drug with expected antiviral activity against COVID-19", "author": "Formiga", "doi-asserted-by": "crossref", "first-page": "758", "journal-title": "J Control Release", "key": "10.1016/j.ijpharm.2022.121719_b0080", "volume": "329", "year": "2021" }, { "DOI": "10.1111/j.2042-7158.2010.01207.x", "article-title": "Preparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous delivery", "author": "Foroozesh", "doi-asserted-by": "crossref", "first-page": "322", "journal-title": "The Journal of pharmacy and pharmacology", "key": "10.1016/j.ijpharm.2022.121719_b0085", "volume": "63", "year": "2011" }, { "DOI": "10.3390/pharmaceutics12050440", "article-title": "Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics", "author": "Glassman", "doi-asserted-by": "crossref", "first-page": "440", "journal-title": "Pharmaceutics", "key": "10.1016/j.ijpharm.2022.121719_b0090", "volume": "12", "year": "2020" }, { "DOI": "10.1208/s12248-007-9000-9", "article-title": "The pharmacokinetics and interactions of ivermectin in humans–a mini-review", "author": "González Canga", "doi-asserted-by": "crossref", "first-page": "42", "issue": "1", "journal-title": "The AAPS journal", "key": "10.1016/j.ijpharm.2022.121719_b0095", "volume": "10", "year": "2008" }, { "DOI": "10.1016/j.nantod.2015.06.006", "article-title": "Nanoparticle Uptake: The Phagocyte Problem", "author": "Gustafson", "doi-asserted-by": "crossref", "first-page": "487", "issue": "4", "journal-title": "Nano Today", "key": "10.1016/j.ijpharm.2022.121719_b0100", "volume": "10", "year": "2015" }, { "DOI": "10.1038/s41429-020-0336-z", "article-title": "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen", "author": "Heidary", "doi-asserted-by": "crossref", "first-page": "593", "issue": "9", "journal-title": "The Journal of antibiotics", "key": "10.1016/j.ijpharm.2022.121719_b0105", "volume": "73", "year": "2020" }, { "DOI": "10.1016/j.bioactmat.2021.09.012", "article-title": "Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size", "author": "Hoemann", "doi-asserted-by": "crossref", "first-page": "430", "journal-title": "Bioact. Mater.", "key": "10.1016/j.ijpharm.2022.121719_b0110", "volume": "10", "year": "2022" }, { "DOI": "10.1016/j.biomaterials.2020.120159", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0115", "unstructured": "Hu, C., Lei, T., Wang, Y., Cao, J., Yang, X., Qin, L., Liu, R., Zhou, Y., Tong, F., Umeshappa, C.S., Gao, H., 2020. Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity. Biomaterials 255, 120159." }, { "DOI": "10.1002/jps.23417", "article-title": "Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release", "author": "Ibrahim", "doi-asserted-by": "crossref", "first-page": "1036", "journal-title": "J. Pharm. Sci.", "key": "10.1016/j.ijpharm.2022.121719_b0120", "volume": "102", "year": "2013" }, { "DOI": "10.1016/j.xphs.2020.08.024", "article-title": "Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing", "author": "Jermain", "doi-asserted-by": "crossref", "first-page": "3574", "issue": "12", "journal-title": "J. Pharm. Sci.", "key": "10.1016/j.ijpharm.2022.121719_b0125", "volume": "109", "year": "2020" }, { "article-title": "MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell cycle (Georgetown", "author": "Ju", "first-page": "2001", "journal-title": "Tex.)", "key": "10.1016/j.ijpharm.2022.121719_b0130", "volume": "17", "year": "2018" }, { "DOI": "10.1007/s43440-020-00195-y", "article-title": "Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes", "author": "Kaur", "doi-asserted-by": "crossref", "first-page": "736", "issue": "3", "journal-title": "Pharmacological reports : PR", "key": "10.1016/j.ijpharm.2022.121719_b0135", "volume": "73", "year": "2021" }, { "DOI": "10.1016/j.eclinm.2021.100959", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0140", "unstructured": "Krolewiecki, A., Lifschitz, A., Moragas, M., Travacio, M., Valentini, R., Alonso, D.F., Solari, R., Tinelli, M.A., Cimino, R.O., Álvarez, L., Fleitas, P.E., Ceballos, L., Golemba, M., Fernández, F., Fernández de Oliveira, D., Astudillo, G., Baeck, I., Farina, J., Cardama, G.A., Mangano, A., Spitzer, E., Gold, S., Lanusse, C., 2021. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. EClinicalMedicine 37, 100959." }, { "DOI": "10.1182/blood-2010-10-313239", "article-title": "Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver", "author": "Lee", "doi-asserted-by": "crossref", "first-page": "5215", "journal-title": "Blood", "key": "10.1016/j.ijpharm.2022.121719_b0145", "volume": "117", "year": "2011" }, { "DOI": "10.3390/cells8080881", "article-title": "Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles", "author": "Li", "doi-asserted-by": "crossref", "first-page": "881", "issue": "8", "journal-title": "Cells", "key": "10.1016/j.ijpharm.2022.121719_b0150", "volume": "8", "year": "2019" }, { "DOI": "10.1002/jcp.30055", "article-title": "Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment", "author": "Li", "doi-asserted-by": "crossref", "first-page": "2959", "issue": "4", "journal-title": "J. Cell. Physiol.", "key": "10.1016/j.ijpharm.2022.121719_b0155", "volume": "236", "year": "2021" }, { "DOI": "10.1016/j.jconrel.2020.02.043", "article-title": "Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "589", "journal-title": "J Control Release", "key": "10.1016/j.ijpharm.2022.121719_b0160", "volume": "321", "year": "2020" }, { "DOI": "10.1001/jama.2021.3071", "article-title": "Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial", "author": "López-Medina", "doi-asserted-by": "crossref", "first-page": "1426", "journal-title": "JAMA", "key": "10.1016/j.ijpharm.2022.121719_b0165", "volume": "325", "year": "2021" }, { "DOI": "10.1016/j.cyto.2020.155151", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0170", "unstructured": "Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., Nabipour, I., 2020. COVID-19 cytokine storm: The anger of inflammation. Cytokine 133, 155151." }, { "DOI": "10.1001/jama.282.21.2035", "article-title": "Hemodynamic shear stress and its role in atherosclerosis", "author": "Malek", "doi-asserted-by": "crossref", "first-page": "2035", "journal-title": "JAMA", "key": "10.1016/j.ijpharm.2022.121719_b0175", "volume": "282", "year": "1999" }, { "DOI": "10.1172/JCI60331", "article-title": "The acute respiratory distress syndrome", "author": "Matthay", "doi-asserted-by": "crossref", "first-page": "2731", "issue": "8", "journal-title": "J Clin Invest", "key": "10.1016/j.ijpharm.2022.121719_b0180", "volume": "122", "year": "2012" }, { "DOI": "10.1111/j.1537-2995.2009.02095.x", "article-title": "Red blood cell volume can be independently determined in vitro using sheep and human red blood cells labeled at different densities of biotin", "author": "Mock", "doi-asserted-by": "crossref", "first-page": "1178", "journal-title": "Transfusion", "key": "10.1016/j.ijpharm.2022.121719_b0185", "volume": "49", "year": "2009" }, { "DOI": "10.1208/s12249-021-02089-5", "article-title": "Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19", "author": "Mohanty", "doi-asserted-by": "crossref", "first-page": "214", "journal-title": "AAPS PharmSciTech", "key": "10.1016/j.ijpharm.2022.121719_b0190", "volume": "22", "year": "2021" }, { "DOI": "10.1016/j.resp.2014.10.006", "article-title": "Biomarkers in acute lung injury", "author": "Mokra", "doi-asserted-by": "crossref", "first-page": "52", "journal-title": "Respir. Physiol. Neurobiol.", "key": "10.1016/j.ijpharm.2022.121719_b0195", "volume": "209", "year": "2015" }, { "DOI": "10.3109/03639045.2013.775581", "article-title": "5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies", "author": "Öcal", "doi-asserted-by": "crossref", "first-page": "560", "issue": "4", "journal-title": "Drug Dev. Ind. Pharm.", "key": "10.1016/j.ijpharm.2022.121719_b0200", "volume": "40", "year": "2014" }, { "DOI": "10.2147/IJN.S38378", "article-title": "Nanodrugs: pharmacokinetics and safety", "author": "Onoue", "doi-asserted-by": "crossref", "first-page": "1025", "journal-title": "Int. J. Nanomed.", "key": "10.1016/j.ijpharm.2022.121719_b0205", "volume": "9", "year": "2014" }, { "DOI": "10.1371/journal.pone.0152074", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0210", "unstructured": "Pan, D., Vargas-Morales, O., Zern, B., Anselmo, A.C., Gupta, V., Zakrewsky, M., Mitragotri, S., Muzykantov, V., 2016. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells. PloS one 11, e0152074." }, { "DOI": "10.1111/bcp.14476", "article-title": "Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19", "author": "Peña‐Silva", "doi-asserted-by": "crossref", "first-page": "1589", "issue": "3", "journal-title": "Br. J. Clin. Pharmacol.", "key": "10.1016/j.ijpharm.2022.121719_b0215", "volume": "87", "year": "2021" }, { "DOI": "10.1021/nl302638g", "article-title": "PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics", "author": "Perry", "doi-asserted-by": "crossref", "first-page": "5304", "issue": "10", "journal-title": "Nano Lett", "key": "10.1016/j.ijpharm.2022.121719_b0220", "volume": "12", "year": "2012" }, { "DOI": "10.1002/cpt.1889", "article-title": "The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19", "author": "Schmith", "doi-asserted-by": "crossref", "first-page": "762", "issue": "4", "journal-title": "Clin. Pharmacol. Ther.", "key": "10.1016/j.ijpharm.2022.121719_b0225", "volume": "108", "year": "2020" }, { "DOI": "10.1021/acsnano.9b02807", "article-title": "Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus", "author": "Surnar", "doi-asserted-by": "crossref", "first-page": "11034", "issue": "10", "journal-title": "ACS Nano", "key": "10.1016/j.ijpharm.2022.121719_b0230", "volume": "13", "year": "2019" }, { "DOI": "10.1038/nnano.2013.181", "article-title": "Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology", "author": "Tenzer", "doi-asserted-by": "crossref", "first-page": "772", "issue": "10", "journal-title": "Nat. Nanotechnol.", "key": "10.1016/j.ijpharm.2022.121719_b0235", "volume": "8", "year": "2013" }, { "DOI": "10.1016/j.rvsc.2010.09.016", "article-title": "Ivermectin effects on motor coordination and contractions of isolated rat diaphragm", "author": "Trailovic", "doi-asserted-by": "crossref", "first-page": "426", "issue": "3", "journal-title": "Res. Vet. Sci.", "key": "10.1016/j.ijpharm.2022.121719_b0240", "volume": "91", "year": "2011" }, { "DOI": "10.1292/jvms.10-0424", "article-title": "Central and peripheral neurotoxic effects of ivermectin in rats", "author": "Trailovic", "doi-asserted-by": "crossref", "first-page": "591", "issue": "5", "journal-title": "The Journal of veterinary medical science", "key": "10.1016/j.ijpharm.2022.121719_b0245", "volume": "73", "year": "2011" }, { "DOI": "10.1016/j.addr.2016.02.007", "article-title": "Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems", "author": "Villa", "doi-asserted-by": "crossref", "first-page": "88", "journal-title": "Adv. Drug Deliv. Rev.", "key": "10.1016/j.ijpharm.2022.121719_b0250", "volume": "106", "year": "2016" }, { "DOI": "10.4155/tde.15.34", "article-title": "Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier", "author": "Villa", "doi-asserted-by": "crossref", "first-page": "795", "issue": "7", "journal-title": "Therapeutic delivery", "key": "10.1016/j.ijpharm.2022.121719_b0255", "volume": "6", "year": "2015" }, { "DOI": "10.1016/j.transci.2016.10.017", "article-title": "Drug delivery by erythrocytes: “Primum non nocere”", "author": "Villa", "doi-asserted-by": "crossref", "first-page": "275", "issue": "3", "journal-title": "Transfus Apher Sci", "key": "10.1016/j.ijpharm.2022.121719_b0260", "volume": "55", "year": "2016" }, { "DOI": "10.1177/1087057110390360", "article-title": "An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import", "author": "Wagstaff", "doi-asserted-by": "crossref", "first-page": "192", "issue": "2", "journal-title": "J. Biomol. Screen.", "key": "10.1016/j.ijpharm.2022.121719_b0265", "volume": "16", "year": "2011" }, { "DOI": "10.1016/j.ijpharm.2020.120084", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0275", "unstructured": "Wang, Y., Zhou, C., Ding, Y., Liu, M., Tai, Z., Jin, Q., Yang, Y., Li, Z., Yang, M., Gong, W., Gao, C., 2021. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K(1). International journal of pharmaceutics 592, 120084." }, { "DOI": "10.1002/jcp.1040770208", "article-title": "Cell surface negativity and the binding of positively charged particles", "author": "Weiss", "doi-asserted-by": "crossref", "first-page": "179", "issue": "2", "journal-title": "J. Cell. Physiol.", "key": "10.1016/j.ijpharm.2022.121719_b0280", "volume": "77", "year": "1971" }, { "DOI": "10.1021/nn700256c", "article-title": "Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways", "author": "Xia", "doi-asserted-by": "crossref", "first-page": "85", "issue": "1", "journal-title": "ACS Nano", "key": "10.1016/j.ijpharm.2022.121719_b0285", "volume": "2", "year": "2008" }, { "DOI": "10.1007/s00011-011-0307-8", "article-title": "Anti-inflammatory effects of ivermectin in mouse model of allergic asthma", "author": "Yan", "doi-asserted-by": "crossref", "first-page": "589", "issue": "6", "journal-title": "Inflamm Res", "key": "10.1016/j.ijpharm.2022.121719_b0290", "volume": "60", "year": "2011" }, { "DOI": "10.1016/j.bioactmat.2020.12.010", "article-title": "The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment", "author": "Yang", "doi-asserted-by": "crossref", "first-page": "1973", "issue": "7", "journal-title": "Bioact. Mater.", "key": "10.1016/j.ijpharm.2022.121719_b0295", "volume": "6", "year": "2021" }, { "DOI": "10.1016/j.antiviral.2020.104760", "doi-asserted-by": "crossref", "key": "10.1016/j.ijpharm.2022.121719_b0300", "unstructured": "Yang, S.N.Y., Atkinson, S.C., Wang, C., Lee, A., Bogoyevitch, M.A., Borg, N.A., Jans, D.A., 2020. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer. Antiviral research 177, 104760." }, { "DOI": "10.1080/10717544.2021.1949075", "article-title": "Aging erythrocyte membranes as biomimetic nanometer carriers of liver-targeting chromium poisoning treatment", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "1455", "issue": "1", "journal-title": "Drug Deliv", "key": "10.1016/j.ijpharm.2022.121719_b0305", "volume": "28", "year": "2021" }, { "DOI": "10.1021/nn2013904", "article-title": "Impact of silica nanoparticle design on cellular toxicity and hemolytic activity", "author": "Yu", "doi-asserted-by": "crossref", "first-page": "5717", "issue": "7", "journal-title": "ACS Nano", "key": "10.1016/j.ijpharm.2022.121719_b0310", "volume": "5", "year": "2011" }, { "DOI": "10.1039/C8NR07730D", "article-title": "Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth", "author": "Zelepukin", "doi-asserted-by": "crossref", "first-page": "1636", "issue": "4", "journal-title": "Nanoscale", "key": "10.1016/j.ijpharm.2022.121719_b0315", "volume": "11", "year": "2019" }, { "DOI": "10.1021/acsami.7b16096", "article-title": "Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "9094", "issue": "10", "journal-title": "ACS Appl. Mater. Interfaces", "key": "10.1016/j.ijpharm.2022.121719_b0320", "volume": "10", "year": "2018" }, { "DOI": "10.3390/pharmaceutics10040286", "article-title": "Autologous Red Blood Cell Delivery of Betamethasone Phosphate Sodium for Long Anti-Inflammation", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "286", "journal-title": "Pharmaceutics", "key": "10.1016/j.ijpharm.2022.121719_b0325", "volume": "10", "year": "2018" }, { "DOI": "10.1007/s00011-008-8007-8", "article-title": "Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "524", "issue": "11", "journal-title": "Inflamm. Res.", "key": "10.1016/j.ijpharm.2022.121719_b0330", "volume": "57", "year": "2008" } ], "reference-count": 65, "references-count": 65, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0378517322002745" } }, "score": 1, "short-container-title": [ "International Journal of Pharmaceutics" ], "short-title": [], "source": "Crossref", "subject": [ "Pharmaceutical Science" ], "subtitle": [], "title": [ "Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties" ], "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "619" }